Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Motor Activity 22Breast Neoplasms 14Neoplasms 9Fatigue 5Prostatic Neoplasms 4Obesity 4Pancreatic Neoplasms 3Colorectal Neoplasms 3Peripheral Nervous System Diseases 2Overweight 2Neoplasm Metastasis 2Multiple Myeloma 2Lung Neoplasms 2Cognitive Dysfunction 2Cardiovascular Diseases 2Urogenital Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Smoking 1Skin Neoplasms 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Ovarian Neoplasms 1Osteolysis 1Non-alcoholic Fatty Liver Disease 1Neuroectodermal Tumors, Primitive 1Neurocognitive Disorders 1Multiple Endocrine Neoplasia Type 1 1Metabolic Syndrome 1

Interventions

pembrolizumab 7cemiplimab 6Nivolumab 5avelumab 3encorafenib 2binimetinib 2Radiotherapy 2Ipilimumab 2Immune Checkpoint Inhibitors 2toripalimab 1tislelizumab 1lifileucel 1lenvatinib 1durvalumab 1dostarlimab 1cobimetinib 1atezolizumab 1Vemurafenib 1Surveys and Questionnaires 1Sirolimus 1Radiosurgery 1Prednisone 1Paclitaxel 1Oxaliplatin 1Observation 1Mohs Surgery 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Magnetic Resonance Spectroscopy 1MAPRE1 protein, human 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Skin Neoplasms × Exercise × Clear all
NCT05358938 2026-02-06

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

H. Lee Moffitt Cancer Center and Research Institute

Phase EARLY_PHASE1 Active not recruiting
22 enrolled
Dermatologic

Melanoma, Motor Activity, Skin Neoplasms, Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡